Amgen Expands Global R&D Capabilities with New Science & Innovation Center in Hyderabad

Amgen is expanding its global research and development capabilities by establishing a new Science & Innovation Center in Hyderabad's Genome Valley. The facility, expected to become operational in 2027, will be part of Amgen's global network of seven research laboratories.

The center will focus on integrating advanced scientific capabilities with data and digital innovation to accelerate the discovery and development of innovative medicines. It will bring together scientists and technologists working across discovery chemistry, drug metabolism and pharmacokinetics, and precision medicine.

'The new center in Genome Valley expands the way we integrate experimental science with data and technology across our global research capabilities,' said Jay Bradner, M.D., Executive Vice President of Research and Development, Artificial Intelligence and Data at Amgen. 'By connecting these capabilities, we can learn faster and translate those insights into innovative medicines for patients.'

Amgen's decision to establish its Science and Innovation Center in Genome Valley reflects Hyderabad's growing role as a global hub for high-value research, bringing together scientific talent, technology, and industry at scale.